Citation 2500

SHEN,YC: CHENG,KC: LIN,YC: CHENG,YB: KHALIL,AT: GUH,JH: CHIEN,CT: TENG,CM: CHANG,YT:. (2005). THREE NEW TAXANE DITERPENOIDS FROM TAXUS SUMATRANA. 68(1)

Citation Details

Title	THREE NEW TAXANE DITERPENOIDS FROM TAXUS SUMATRANA
Authors	SHEN,YC: CHENG,KC: LIN,YC: CHENG,YB: KHALIL,AT: GUH,JH: CHIEN,CT: TENG,CM: CHANG,YT:
Year	2005
Volume	68
Issue	1

Summary

Year: 2005

Journal: Unknown

Organisms and Their Experiments (1)

Taxus sumatrana (TAXACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	VOUCHER SPECIMEN REPORTED FOR	None	None
2	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	TASUMATROL E	None
3	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	TASUMATROL E	ACTIVE
4	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	TASUMATROL E	ACTIVE
5	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	TASUMATROL E	ACTIVE
6	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	TASUMATROL E	ACTIVE
7	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	TASUMATROL F	None
8	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	TASUMATROL F	ACTIVE
9	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	TASUMATROL F	ACTIVE
10	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	TASUMATROL F	ACTIVE
11	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	TASUMATROL F	ACTIVE
12	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	TASUMATROL G	None
13	ANTIAPLASTIC ANEMIA ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	TASUMATROL G	EQUIVOCAL
14	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	TASUMATROL G	ACTIVE
15	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	TASUMATROL G	EQUIVOCAL
16	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	TASUMATROL G	ACTIVE
17	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	TAXININ M	None
18	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	TAXININ M	EQUIVOCAL
19	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	TAXININ M	EQUIVOCAL
20	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	TAXININ M	EQUIVOCAL
21	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	TAXININ M	INACTIVE
22	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	TAXA-4(20)-11-DIENE,2-ALPHA-5-ALPHA-DIHYDROXY-7-BETA-9-ALPHA-10-BETA-13-ALPHA-TETRAACETOXY:	None
23	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	TAXAGIFIN,2-ALPHA-DEACETYL-5-ALPHA-DECINNAMOYL:	None
24	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	WALLIFOLIOL	None
25	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	WALLIFOLIOL	WEAK ACTIVITY
26	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	WALLIFOLIOL	WEAK ACTIVITY
27	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	WALLIFOLIOL	EQUIVOCAL
28	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	WALLIFOLIOL	EQUIVOCAL
29	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	BACCATIN III,10-DEACETYL:	None
30	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BACCATIN III,10-DEACETYL:	WEAK ACTIVITY
31	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BACCATIN III,10-DEACETYL:	EQUIVOCAL
32	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BACCATIN III,10-DEACETYL:	EQUIVOCAL
33	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BACCATIN III,10-DEACETYL:	EQUIVOCAL
34	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	BACCATIN IV,ABEO: 10-13-DEACETYL:	None
35	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BACCATIN IV,ABEO: 10-13-DEACETYL:	EQUIVOCAL
36	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BACCATIN IV,ABEO: 10-13-DEACETYL:	EQUIVOCAL
37	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BACCATIN IV,ABEO: 10-13-DEACETYL:	WEAK ACTIVITY
38	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BACCATIN IV,ABEO: 10-13-DEACETYL:	EQUIVOCAL
39	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	BACCATIN III,10-DEACETYL-13-OXO	None
40	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BACCATIN III,10-DEACETYL-13-OXO	WEAK ACTIVITY
41	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BACCATIN III,10-DEACETYL-13-OXO	WEAK ACTIVITY
42	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BACCATIN III,10-DEACETYL-13-OXO	WEAK ACTIVITY
43	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BACCATIN III,10-DEACETYL-13-OXO	ACTIVE
44	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	BACCATIN III,19-HYDROXY-13-OXO:	None
45	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BACCATIN III,19-HYDROXY-13-OXO:	ACTIVE
46	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BACCATIN III,19-HYDROXY-13-OXO:	ACTIVE
47	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BACCATIN III,19-HYDROXY-13-OXO:	WEAK ACTIVITY
48	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BACCATIN III,19-HYDROXY-13-OXO:	ACTIVE
49	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	BACCATIN III,19-HYDROXY-10-DEACETYL:	None
50	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BACCATIN III,19-HYDROXY-10-DEACETYL:	EQUIVOCAL
51	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BACCATIN III,19-HYDROXY-10-DEACETYL:	WEAK ACTIVITY
52	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BACCATIN III,19-HYDROXY-10-DEACETYL:	INACTIVE
53	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BACCATIN III,19-HYDROXY-10-DEACETYL:	EQUIVOCAL
54	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	BACCATIN III,19-HYDROXY:	None
55	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BACCATIN III,19-HYDROXY:	WEAK ACTIVITY
56	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BACCATIN III,19-HYDROXY:	WEAK ACTIVITY
57	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BACCATIN III,19-HYDROXY:	INACTIVE
58	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BACCATIN III,19-HYDROXY:	WEAK ACTIVITY
59	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	TAXAYUNTIN G	None
60	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	TAXAYUNTIN G	EQUIVOCAL
61	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	TAXAYUNTIN G	WEAK ACTIVITY
62	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	TAXAYUNTIN G	INACTIVE
63	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	TAXAYUNTIN G	EQUIVOCAL
64	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	BACCATIN III,10-DEACETYL-10-OXO:	None
65	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BACCATIN III,10-DEACETYL-10-OXO:	ACTIVE
66	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BACCATIN III,10-DEACETYL-10-OXO:	ACTIVE
67	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BACCATIN III,10-DEACETYL-10-OXO:	ACTIVE
68	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BACCATIN III,10-DEACETYL-10-OXO:	STRONG ACTIVITY
69	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	TAXOL	ACTIVE
70	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	TAXOL	ACTIVE
71	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	TAXOL	ACTIVE
72	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	TAXOL	ACTIVE

Citation 2500

Citation Details

Summary

Organisms and Their Experiments (1)

Taxus sumatrana (TAXACEAE)

Show SPARQL Queries (1)

Query 1